CRSP CRISPR Therapeutics AG
Healthcare$51.59+2.44%ClosedMarket Cap: $4.98B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$64.60
Target (Median)
$76.00
Target Range
$33.00 - $82.00
Upside from current price: 25.2%
Rating Distribution
4 Strong Buy12 Buy9 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Bernstein | maintain | Market Perform | Market Perform |
| 2026-05-06 | Citigroup | maintain | Buy | Buy |
| 2026-03-17 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-02-17 | Chardan Capital | maintain | Buy | Buy |
| 2026-02-13 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-02-13 | Needham | maintain | Buy | Buy |
| 2026-02-13 | TD Cowen | maintain | Hold | Hold |
| 2026-01-30 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-12-23 | Needham | maintain | Buy | Buy |
| 2025-12-23 | Citizens | maintain | Market Outperform | Market Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.69 | $134.2M | 16 |
| Sun Dec 31 | $-2.25 | $535.0M | 9 |
| Mon Dec 31 | $2.91 | $2.01B | 3 |
| Tue Dec 31 | $15.41 | $5.02B | 3 |